Global Point of Care
Mobile Navigation button
BACK
  • United States
Home > Products

Panbio™ COVID-19 Ag Rapid Test Device

IDENTIFY POTENTIALLY CONTAGIOUS PATIENTS IN 15 MINUTES

For patients suspected of current COVID-19 infection.

High performance rapid test enables immediate treatment or isolation measures to minimize transmission.

Patient-friendly nasal or nasopharyngeal sample collection types.

Accessible, large-scale testing helps contain the virus spread.

Product not available in all countries. Not approved for sale in the USA. 

Benefits
  • Fast identification of potentially contagious individuals
  • Test results in 15 minutes
  • Deploy at large scale at point of care
  • Can be used in a wide variety of non-laboratory settings
  • No special/additional instruments required
  • Self-contained tube with "break off" swab minimizes staff exposure
  • Extraction tube is fully enclosed for disposal
Helpful Documents
  • Test time: 15 minutes
  • Nasal swab vs Nasal PCR:
    Sensitivity 98.1% (99.0% for samples with Ct values ≤ 33) / Specificity 99.8%.
  • Nasal swab vs Nasopharyngeal PCR:
    Sensitivity 91.1% / Specificity 99.7%
  • Nasopharyngeal swab vs Nasopharyngeal PCR:
    Sensitivity 91.4% (94.1% for samples with Ct values ≤ 33) / Specificity 99.8%
  • Storage: 2°C–30°C
  • CE MARK
  • WHO EUL
  • Sample type: Nasal or Nasopharyngeal swab
  • Quantity: 25 tests/kit
Panbio™ COVID-19 Ag Rapid Test Device Code
Panbio™ COVID-19 Ag Rapid Test Device Nasal (25T) 41FK11
Panbio™ COVID-19 Ag Rapid Test Device Nasopharyngeal (25T) 41FK10

Test Availability Updates

For additional information on NAVICA™ Mobile App and BinaxNOW™ COVID-19 Ag Card test availability.

Sign Up Now

Need Technical Support?

Click here to get in touch with our technical support team.

   

False
accessibility

   

YesNo
accessibility

   

YesNo
accessibility

   

YesNo
More Info